A possible breakout setup was detected on MERCK & CO. INC. (NYSE:MRK) by our stockscreener. A breakout pattern is formed when a stock consolidates after a strong rise up. We note that this pattern is detected purely based on technical analysis and whether the breakout actually materializes remains to be seen. It could be interesting to keep an eye on NYSE:MRK.
Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.
Taking everything into account, MRK scores 8 out of 10 in our technical rating. This is due to a consistent overall performance, although we see some doubts in the very recent evolution. In the medium time frame things are still looking good.
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NYSE:MRK currently has a 8 as setup rating:
MRK has an excellent technical rating and also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. A pullback is taking place, which may present a nice opportunity for an entry. There is a support zone below the current price at 109.87, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for MRK in the last couple of days, which is a good sign.
A breakout could materialize when the stock breaks out to new highs above the current consolidation zone. One could wait for this to happen and buy when this happens. A stop loss could be placed below the consolidation zone.
Of course, there are many ways to trade or not trade NYSE:MRK and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.
Our Breakout analyzer lists more breakout setups and is updated daily.
These healthcare titans are poised for a strong showing in 2023 and beyond.
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.
Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a
Merck recently completed its acquisition of a California-based biotech company.
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
The US FDA has granted an additional indication for Merck's (MRK) Keytruda (pembrolizumab) as a adjuvant therapy for non-small cell lung cancer (NSCLC).
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.